Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection

Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int Surg
Päätekijät: Nakamura, Kenichi, Beppu, Toru, Hayashi, Hiromitsu, Okabe, Hirohisa, Imai, Kastunori, Nitta, Hidetoshi, Chikamoto, Akira, Ishiko, Takatoshi, Sasaki, Masato, Baba, Hideo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Aiheet:
Hepatobiliary & Pancreatic Surgery
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/
https://ncbi.nlm.nih.gov/pubmed/26011214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia